Prestige BioPharma Limited (950210.KS)
950210.KS Stock Price Chart
Explore Prestige BioPharma Limited interactive price chart. Choose custom timeframes to analyze 950210.KS price movements and trends.
950210.KS Company Profile
Discover essential business fundamentals and corporate details for Prestige BioPharma Limited (950210.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Feb 2021
Employees
54.00
CEO
So-Yeon Park
Description
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.
950210.KS Financial Timeline
Browse a chronological timeline of Prestige BioPharma Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at ₩838.40 , while revenue for the quarter reached ₩3.34B .
Earnings released on 31 Dec 2024
EPS came in at -₩223.20 , while revenue for the quarter reached ₩3.11B .
Earnings released on 30 Sept 2024
EPS came in at -₩96.26 , while revenue for the quarter reached ₩2.22B .
Earnings released on 25 Sept 2024
EPS came in at -₩23.93 , while revenue for the quarter reached ₩643.03M .
Earnings released on 30 Jun 2024
EPS came in at -₩154.51 , while revenue for the quarter reached -₩137.09M .
Earnings released on 30 Dec 2023
EPS came in at -₩215.85 , while revenue for the quarter reached ₩119.89M .
Earnings released on 30 Sept 2023
EPS came in at -₩151.80 , while revenue for the quarter reached ₩67.32M .
Earnings released on 30 Jun 2023
EPS came in at -₩146.55 , while revenue for the quarter reached ₩161.06M .
Earnings released on 31 Mar 2023
EPS came in at -₩238.84 .
Earnings released on 31 Dec 2022
EPS came in at -₩304.15 .
Earnings released on 30 Sept 2022
EPS came in at ₩985.23 .
Earnings released on 30 Jun 2022
EPS came in at -₩1.68K .
Earnings released on 31 Mar 2022
EPS came in at -₩1.43K .
Earnings released on 31 Dec 2021
EPS came in at -₩231.80 .
Earnings released on 30 Sept 2021
EPS came in at -₩169.27 .
Earnings released on 17 Sept 2021
EPS came in at ₩44.04 .
Earnings released on 29 May 2021
EPS came in at ₩2.33 .
Earnings released on 31 Mar 2021
EPS came in at -₩210.00 , while revenue for the quarter reached ₩572.29M .
Earnings released on 30 Sept 2020
EPS came in at -₩9.59 .
950210.KS Stock Performance
Access detailed 950210.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.